-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H2PR7FnkNghBjR/SqN8cVIUy8X3cEPVIh2DRCHfz/s1pRQhfbOMTY4TXlheJ24ZC 28uy0g84JenAXSdvnXmtkQ== 0000897069-08-001079.txt : 20080620 0000897069-08-001079.hdr.sgml : 20080620 20080620143628 ACCESSION NUMBER: 0000897069-08-001079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080618 FILED AS OF DATE: 20080620 DATE AS OF CHANGE: 20080620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TAYLOR RICHMOND L CENTRAL INDEX KEY: 0001217565 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 08909916 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 MAIL ADDRESS: STREET 1: 4155 E LAPALMA AVE SUITE 400 CITY: ANEHEIM STATE: CA ZIP: 92807 4 1 dkm1538_ex.xml X0202 4 2008-06-18 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001217565 TAYLOR RICHMOND L TWO BETHESDA METRO CENTER, SUITE 1200 BETHESDA MD 20814 0 1 0 0 Executive Vice President Common Stock 2008-06-18 4 S 0 925 15.14 D 70432 D Common Stock 2008-06-18 4 S 0 1400 15.1413 D 69032 D Common Stock 2008-06-18 4 S 0 1000 15.1414 D 68032 D Common Stock 2008-06-18 4 S 0 200 15.1450 D 67832 D Option to Buy 14.23 2003-05-30 2012-05-29 Common Stock 46666 46666 D Option to Buy 1.64 2002-05-31 2009-05-30 Common Stock 23333 23333 D Option to Buy 13.80 2004-08-01 2013-07-31 Common Stock 25000 25000 D The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares. Includes (i) unvested restricted shares which total 22,500 shares of stock from an initial grant of 22,500 shares of restricted stock made on August 9, 2007; (ii) unvested restricted shares and fully vested shares which total 32,802 shares of stock from an initial grant of 40,000 shares of restricted stock made on June 12, 2006; (iii) unvested restricted shares and fully vested shares which total 10,915 shares of stock from an initial grant of 20,000 shares of restricted stock made on March 4, 2005; and (iv) 1,615 shares of stock which were derived from a previous grant of restricted shares which are now fully vested. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. This option was fully vested on June 23, 2005. This option becomes exercisable to the extent of 25% of the shares underlying the option on the above date and is cumulatively exercisable to the extent of 25% of the shares underlying the option at the end of each year thereafter. /s/ Teri L. Champ, attorney-in-fact 2008-06-20 EX-24 2 dkm1538.htm

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS that the person whose signature appears below hereby constitutes and appoints Jay W. Freedman, Arthur H. Bill, Thomas L. James, Christian P. Fonss, Timothy C. Maples, Teri L. Champ, Mariel I. Estigarribia and Matthew B. Bronson, or any one of them, such person’s true and lawful attorney-in-fact and agent, with full power of substitution and revocation, for such person and in such person’s name, place and stead, to sign any report on Form 3, Form 4 or Form 5, in any such case with respect to his or her beneficial ownership of shares of Hanger Orthopedic Group, Inc., common stock, $.01 par value per share (“Common Stock”), and to file the same with the Securities and Exchange Commission and any exchange or similar system for trading on which the Common Stock is or hereafter becomes listed or qualified for trading or quoting.

Dated: May 12, 2008

/s/ Richmond L. Taylor
(Signature)


Richmond L. Taylor
(Printed Name)


Executive Vice President, President and Chief
Operating Officer of Hanger Prosthetics &
Orthotics, Inc. and HPO, Inc.
(Title)
 -----END PRIVACY-ENHANCED MESSAGE-----